We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
+0.81%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$77.2B
AUM Growth
+$3.78B
Cap. Flow
+$3.39B
Cap. Flow %
4.39%
Top 10 Hldgs %
11.56%
Holding
4,729
New
599
Increased
1,385
Reduced
1,503
Closed
674

Top Buys

Rank Stock Value
1
FWONK icon
Liberty Media Series C
FWONK
+$430M
2
BABA icon
Alibaba
BABA
+$364M
3
HPQ icon
HP
HPQ
+$298M
4
PFE icon
Pfizer
PFE
+$258M
5
BKNG icon
Booking.com
BKNG
+$244M

Sector Composition

Rank Sector Weight
1 Technology 8.89%
2 Consumer Discretionary 8.28%
3 Energy 7.75%
4 Healthcare 6.77%
5 Communication Services 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMSC icon
4001
American Superconductor
AMSC
$1.48B
$48K ﹤0.01%
3,430
-32,014
-90% -$547K
FCEL icon
4002
FuelCell Energy
FCEL
$1.7B
$45K ﹤0.01%
5
+3
+150% +$30.5K
ONCT
4003
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$45K ﹤0.01%
44
-14
-24% -$20.6K
VTG
4004
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
$44K ﹤0.01%
34,972
-26,407
-43% -$47.1K
WILN
4005
DELISTED
Wi-LAN Inc.
WILN
$43K ﹤0.01%
12,000
-26,100
-69% -$90.7K
VVUS
4006
DELISTED
Vivus Inc
VVUS
$42K ﹤0.01%
1,097
-5,662
-84% -$253K
HDY
4007
DELISTED
HYPERDYNAMICS CORP (NEW)
HDY
$38K ﹤0.01%
21,168
-500
-2% -$1.29K
LIVE icon
4008
Live Ventures
LIVE
$29.8M
$35K ﹤0.01%
+1,953
New +$44.9K
PRTK
4009
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$31K ﹤0.01%
1,283
-3,693
-74% -$96.4K
STAB
4010
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$31K ﹤0.01%
3,352
TEU
4011
DELISTED
BOX SHIPS INCORPORATED SHS (MARSHALL ISLANDS)
TEU
$31K ﹤0.01%
25,231
-110,507
-81% -$154K
ATLC icon
4012
Atlanticus Holdings
ATLC
$1.5B
$30K ﹤0.01%
16,155
UNIS
4013
DELISTED
Unilife Corporation
UNIS
$27K ﹤0.01%
+1,182
New +$29.9K
MBOT icon
4014
Microbot Medical
MBOT
$115M
$23K ﹤0.01%
11
-7
-39% -$18.5K
CERE
4015
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$23K ﹤0.01%
6,961
GSS
4016
DELISTED
Golden Star Resources Ltd.
GSS
$22K ﹤0.01%
10,495
-1,680
-14% -$4.29K
GMO
4017
DELISTED
General Moly, Inc.
GMO
$22K ﹤0.01%
29,900
MRGE
4018
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$22K ﹤0.01%
10,128
-19,025
-65% -$46.2K
RSH
4019
DELISTED
RADIOSHACK CORP
RSH
$20K ﹤0.01%
20,066
-154,187
-88% -$132K
KBIO
4020
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
$20K ﹤0.01%
1,622
-25
-2% -$345
CACH
4021
DELISTED
CACHE INC (DE)
CACH
$19K ﹤0.01%
22,400
ALBO
4022
DELISTED
Albireo Pharma Inc
ALBO
$18K ﹤0.01%
357
-473
-57% -$27.2K
LFVN icon
4023
LifeVantage
LFVN
$82.4M
$15K ﹤0.01%
1,907
-1,557
-45% -$14.3K
PRKR
4024
DELISTED
Parkervision Inc
PRKR
$15K ﹤0.01%
1,339
-399
-23% -$5.05K
ENZN
4025
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$15K ﹤0.01%
14,073
-25,238
-64% -$31.2K

Similar funds

D.E. Shaw & Co's Q3 2014 Portfolio in Review

As of Q3 2014, D.E. Shaw & Co held 4,729 positions worth $77.2B, up 5.1% from $73.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

D.E. Shaw & Co deployed $3.39B of net new capital in Q3 2014, opening 599 new positions and adding to 1,385 existing holdings. Its largest new stake was Liberty Media Series C: 16,804,239 shares worth $422M.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.9% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Liberty Media Series A, an estimated $321M trimmed.

  • D.E. Shaw & Co's largest Q3 2014 buy was Liberty Media Series C: 16,804,239 shares worth $422M.
  • D.E. Shaw & Co added most to HP in Q3 2014, an estimated $298M increase.
  • D.E. Shaw & Co's biggest Q3 2014 reduction was Liberty Media Series A, cutting an estimated $321M.
  • D.E. Shaw & Co fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $602M.
  • D.E. Shaw & Co's ten largest holdings make up 12% of its $77.2B portfolio in Q3 2014.
  • D.E. Shaw & Co opened 599 new positions and closed 674 in Q3 2014.
  • D.E. Shaw & Co's portfolio value rose 5.1% quarter-over-quarter to $77.2B.

Based on D.E. Shaw & Co's 13F filing for Q3 2014, filed 14 Nov 2014.